Browse subjects in this section:
James R. Heath is the Elizabeth W. Gilloon Professor and Professor of Chemistry at Caltech, and Professor of Molecular & Medical Pharmacology at UCLA, and Director of the National Cancer Institutes NSB Cancer Center.
Leroy Hood’s research has focused on the study of molecular immunology, biotechnology, and genomics. His professional career began at Caltech where he and his colleagues pioneered four instruments—the DNA gene sequencer and synthesizer, and the protein synthesizer and sequencer—which comprise the technological foundation for contemporary molecular biology.
Michael Phelps, the Norton Simon Professor and Chair of the UCLA Department of Molecular and Medical Pharmacology, has been on the faculty of the University of California since 1976. He is actively engaged in medical research, educational programs and multimedia technologies at UCLA. Dr. Phelps uniquely holds six academic positions at UCLA. In addition to serving as the Departmental Chairman and holding an endowed professorship, he is also the Director of the Crump Institute for Molecular Imaging, Professor of Biomathematics, the Director of the Institute for Molecular Medicine and the Chief of Nuclear Medicine.
Dr. Robert H. Grubbs is the Victor and Elizabeth Atkins Professor of Chemistry at the California Institute of Technology, Pasadena, California, USA, where he has been a faculty member since 1978. Before moving to Caltech, he was at Michigan State University from 1969 to 1978 achieving the rank of Associate Professor.
In a Watson lecture on May 14, Mark Davis, NSBCC investigator and Caltech's Schlinger Professor of Chemical Engineering. Davis, also a member of the experimental therapeutics program at the City of Hope's Comprehensive Cancer Center, explained how nanoparticle medicines, or nanomedicines, have the potential to change the way cancer is treated.
Hamilton Jordan, good friend and NSBCC External Advisory Board Member, died in his home of cancer on Tuesday, May 20, 2008.
Roy Doumani, a survivor of prostate cancer, is a native of Los Angeles. He graduated from UCLA with a degree in Business and Finance and received a law degree from the University of Southern California. He is a member of the California NanoSystems Institute (CNSI) Advisory and Oversight Board. Mr. Doumani holds the position of Professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. He also serves as co-chairman of the Zhejiang California NanoSystems Institute (ZCNI) and is chairman of the Business Advisory Board for the governor of Zhejiang Province, China.
Dr. Ruedi Aebersold, one of the pioneers in the field of proteomics, is known for developing a series of methods that have found wide application in analytical protein chemistry and proteomics. Most recently, his group developed a method for the rapid identification and accurate quantification of cellular proteins, i.e. for the generation of cellular "protein profiles";. The method is based on a new class of reagents termed Isotope Coded Affinity Tags or ICAT reagents, and mass spectrometry.
Hong Wu is a Professor of Molecular and Medical Pharmacology at UCLA School of Medicine, and a member of UCLA Molecular Biology Institute and Jonsson Comprehensive Cancer Center. She is the Director of the UCLA Molecular Genetics Technology Center and the co-director of Cancer Stem Cell Program area of the newly formed UCLA Institute for Stem Cell Biology and Medicine.
Grab the RSS newsfeed for this category: